Angel is a 4 year 6-month-old female entire Jack Russel Terrier cross. She has been with her family since she was a puppy and has visited her local veterinary practice for regular health checks. Except for a diagnosis of Granulomatous meningioencephalitis in June 2022, Angel has been a healthy dog.
In September 2022, Angel started vomiting therefore her mum took
her to their local veterinary practice for re-assessment. Her mum also reported
a lump under her chin. A physical examination confirmed that she had enlarged
submandibular lymph nodes. A needle sample was taken from the left
submandibular lymph node and cytology results confirmed the presence a high
grade, large cell lymphoma. Angel was referred to our oncology hospital for
further investigation and to discuss treatment options.
In October 2022, Angel presented for an initial consultation with
Oncology, Dr Iain Grant. More needle aspirates were taken of the lymph nodes to
run an additional test called Flow cytometry. This test was performed to give
us more information regarding which type of lymphoma was present. This allowed
the oncologist to determine the best treatment to administer and understand her
estimated survival time. Results confirmed she had a diffuse B cell lymphoma
and Angel started chemotherapy straight away. Angel underwent a 25-week
chemotherapy protocol called “CHOP”. This is the most common chemotherapy
protocol for canine lymphoma and provides the best survival time of
approximately 10-12 months. The protocol consists of three chemotherapy agents
(cyclophosphamide, doxorubicin and vincristine) and an oral steroid
(prednisolone). Angel attended 8 visits at weekly visits and then another 8
treatments at fortnightly intervals. In April 2023, Angel received her final
chemotherapy treatment and was confirmed to be in full remission. She visited
our hospital for monthly physical examinations to assess her lymph nodes and
ensure she remained in complete remission. Her family monitored her closely at
home for any changes in her health.
Angel remained in remission for three months but sadly in July
2023 her mum contacted the hospital to report that a lymph node was enlarged in
her neck, and she came for an urgent appointment. Cytology confirmed she had
relapsed, and re-induction therapy was discussed. She re-started her second
round of the 25-week CHOP protocol and is still currently undergoing
chemotherapy treatment with our chemotherapy team and is still responding well
to treatment after 13 months.
Despite having chemotherapy, Angel continues to maintain an
excellent quality of life and do all of her favorite things. Although small,
Angel has always had a larger-than-life personality. She has a sweet little
walk and everyone in the hospital knows her name. From reception, the
management team to the directors of Aura, Angel has many friends, and everybody
welcomes her for each of her appointments.
From the families perspective .........
We chatted with Angel’s family, to hear how she came to visit AURA and how they feel Angel is getting on with her treatment.
What were Angel’s first symptoms that made you take her to your local vet?
Before being referred to AURA for specialist treatment did you know that referral practices were an option?
How have you found treatment at AURA over the past year?
How is Angel doing?
Knowing what you know now what would you advise another owner in a similar situation?
A big thank you to Angel’s family for getting involved with raising awareness for Pet Cancer Awareness Month!
Please do click the link below to see our Instagram where you can watch a behind the scenes video Angel receiving intravenous chemotherapy!